Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: J Natl Compr Canc Netw. 2011 Sep 1;9(9):1060–1071. doi: 10.6004/jnccn.2011.0087

Figure 1.

Figure 1

The effect of chemosensitive disease at time of autologous stem cell transplant on overall (A) and progression-free survival (B) of relapsed and refractory Hodgkin lymphoma. Abbreviations: Chemo, chemotherapy; CR, complete remission; PR, partial remission.

From Sirohi B, Cunningham D, Powles R, et al. Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin’s lymphoma. Ann Oncol 2008;19:1312–1319; by permission of Oxford University Press.